Drug profile

The FDA adverse-event record for Cranberry Supplement (Unknown)

42 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Cranberry Supplement (Unknown). See the species affected, top reactions, and outcomes below.

42
adverse-event reports
14.3%
death-coded share
Dog
most-reported species
10
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
42
Total Reports
6
Deaths Reported
14.3%
Death Rate

Active Ingredients

Cranberry Supplement (Unknown)

Administration Routes

OralUnknown

Species Affected

Dog 38
Cat 4

Most Affected Breeds

Shih Tzu 3
Boxer (German Boxer) 3
Siberian Husky 2
Bichon Frise 2
Schnauzer - Miniature 2
Retriever - Golden 2
Terrier - West Highland White 2
Bulldog 2
Terrier - Bull - Staffordshire 2
Retriever - Labrador 2

Most Reported Reactions

Vomiting 10
Emesis 9
Lethargy (see also Central nervous system depression in 'Neurological') 7
Behavioural disorder NOS 6
Death by euthanasia 6
Diarrhoea 3
Not eating 3
Lethargy (see also Central nervous system depression in Neurological) 3
Urinary incontinence 3
Seizure NOS 2
Elevated amylase 2
Elevated lipase 2

Outcome Breakdown

Recovered/Normal
20 (47.6%)
Outcome Unknown
9 (21.4%)
Euthanized
6 (14.3%)
Ongoing
5 (11.9%)
Recovered with Sequela
2 (4.8%)

Cranberry Supplement (Unknown) Adverse Event Insights

42 reports name Cranberry Supplement (Unknown); 6 recorded a death outcome (14.3% of reported events, not a population-level mortality rate). Active ingredient: Cranberry Supplement (Unknown). Administration routes: Oral, Unknown.

By species: Dog (38 reports), Cat (4 reports). By breed: Shih Tzu (3), Boxer (German Boxer) (3), Siberian Husky (2).

Leading clinical signs: Vomiting (10), Emesis (9), Lethargy (see also Central nervous system depression in 'Neurological') (7), Behavioural disorder NOS (6). Outcome, 42 coded reports: Recovered/Normal leads at 47.6%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.